NeuRx Diaphragm Pacing System use approved by Health Canada
DECEMBER, VANCOUVER, BC - U.S.-based Synapse Biomedical has received approval from Health Canada for its NeuRx Diaphragm Pacing System (DPS), designed to assist people with spinal cord injuries (SCI) who lack control of their diaphragms and are ventilator-dependent.
With this Health Canada approval, SCI patients throughout Canada can access this technology that was only previously available to clinical trial participants or through the Medical Devices Special Access Program.
The approval is based on patient data supplied from clinical trials at hospitals in the US and Canada, including Vancouver General Hospital, and is a great example of the power of the Rick Hansen Institute network.